AbbVie and Genmab report data from follicular lymphoma antibody trial

AbbVie and Genmab report data from follicular lymphoma antibody trial

Submitted by admin on December 11, 2023 - 9:59am
Source: 
Clinical Trials Arena
News Tags: 
AbbVie
Genman
clinical trials
epcoritamab
bispecific antibodies
relapsed or refractory follicular lymphoma
Headline: 
AbbVie and Genmab report data from follicular lymphoma antibody trial
snippet: 

AbbVie and Genmab have reported data from the Phase I/II EPCORE NHL-1 clinical trial of T-cell engaging bispecific antibody epcoritamab (DuoBody CD3xCD20) in adults with relapsed/refractory (r/r) follicular lymphoma (FL).

Do Not Allow Advertisers to Use My Personal information